Shareholding disclosure

Vifor Pharma AG

Collectively declared rate

93.92%

Threshold

Crossed upwards

Timeline

Published

31.03.2022

Transaction

22.03.2022

Voting rights breakdown

Voting rights acquired93.92%

Voting rights sold0.69%

Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBM3T00027

Beneficial owner

CSL Limited

Declared address

CSL Limited, Melbourne

End of the additional acceptance period (Nachfrist) of the public tender offer (art. 20 para. 2 FMIO-FINMA) Remarks: On December 14, 2021, immediately prior to the publication of the pre-announcement (Voranmeldung) regarding the public tender offer, CSL Limited and Vifor Pharma AG entered into a transaction agreement regarding such public tender offer. The public tender offer is currently expected to complete around middle of calendar year 2022. CSL Behring AG being the Offeror in the public tender offer; for the positions attributable to CSL Limited

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Vifor Pharma AG

Vifor Pharma AG31.03.2022TBM3T00027

Disclosure summary

CSL Limited disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 31.03.2022, at 93.92% of voting rights. The filing groups 2 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

2 people

93.92%

Voting rights acquired

Voting rights acquired93.92%

Voting rights sold0.69%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 2 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

CSL Limited disclosed a holding in Vifor Pharma AG, published on 31.03.2022.

Publication date31.03.2022

Transaction date22.03.2022

Issuing companyVifor Pharma AG

Beneficial ownerCSL Limited

Declared addressCSL Limited, Melbourne

CategoryGroup of shareholders

Voting rights acquired93.92%

Voting rights sold0.69%

Below threshold0%

ExchangeXSWX

Notification IDTBM3T00027

Conditions

End of the additional acceptance period (Nachfrist) of the public tender offer (art. 20 para. 2 FMIO-FINMA) Remarks: On December 14, 2021, immediately prior to the publication of the pre-announcement (Voranmeldung) regarding the public tender offer, CSL Limited and Vifor Pharma AG entered into a transaction agreement regarding such public tender offer. The public tender offer is currently expected to complete around middle of calendar year 2022. CSL Behring AG being the Offeror in the public tender offer; for the positions attributable to CSL Limited

Source: SIX Exchange Regulation · Publication date: 31.03.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open